BeStock  
Markets › Compare › LGND vs IMVT

LGND vs IMVT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
LGND · Ligand Pharmaceuticals$286.85 ▼ 0.03%
IMVT · Immunovant$31.77 ▼ 2.31%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

82111140170199Nov 24, '25May 26, '26Nov 20, '26
  • LGND +38.6%
  • IMVT +36.2%

Head to head

MetricLGNDIMVT
Price$286.85$31.77
Change today▼ 0.03%▼ 2.31%
Market cap$5.74B$6.57B
Return, 3 months+2.4%-26.7%
Return, year to date+51.7%+25.0%
Return, 1 year+44.0%+40.6%
P/E (TTM)115.2–
P/B6.010.0
P/E percentile vs own 5y99th28th
Dividend yield––
Revenue growth (YoY, latest qtr)-31.8%–
Net profit growth (YoY)-124.3%+23.1%
Gross margin95.2%–
Operating margin14.4%–
Net margin20.3%–
Return on equity5.4%-86.5%
Analyst target vs. price+27.9%+52.4%
Analyst buy share100%75%
RSI (14)3948
30-day volatility38.6%62.7%
Max drawdown, 1 year-14.7%-40.5%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • IMVT is the largest of the group by market value.
  • LGND has returned the most over the past year.
  • LGND has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top